PTC grabs $10M milestone; Sarepta scales up eteplirsen manufacturing as it preps for '14 NDA;

@FierceBiotech: Ousted scientist fires back at GSK's high-pressure R&D strategy in China. Story | Follow @FierceBiotech

@JohnCFierce: Is the silly season on biotech IPOs over? No, Intrexon debuts with $2B market value. Item | Follow @JohnCFierce

@RyanMFierce: Biotech M&A gossip: Amgen buyout of Onyx could happen soon. More | Follow @RyanMFierce

@EmilyMFierce: NIH to open genomic data of HeLa cells to researchers. Article | Follow @EmilyMFierce

> PTC Therapeutics ($PTCT) snagged a $10 million milestone following the selection of a development candidate in its spinal muscular atrophy collaboration with Roche ($RHBBY) and the SMA Foundation. Release

> Cambridge, MA-based Sarepta Therapeutics ($SRPT) says it is ramping up its manufacturing of eteplirsen as it prepares to seek an accelerated approval for the Duchenne muscular dystrophy therapy in the first half of 2014. Release

> Silence Therapeutics says that it has dosed the first patients with pancreatic cancer in a Phase IIa study of Atu027. Story

Medical Device News

@FierceMedDev: Alere declares victory in proxy challenge. Article | Follow @FierceMedDev

@DamianFierce: Losses mounting, Invacare sells off another unit for $45M. Story | Follow @DamianFierce

@MichaelGFierce: Luminex axing 5% of workforce as reimbursement dries up. Article | Follow @MichaelGFierce

> CareFusion saddled with yet another Class I recall. More

> SetPoint snags $27M from GSK, Covidien. Story

> Thermo lops off 240 jobs as it preps for Life Tech merger. Article

Pharma News

@FiercePharma: Tyson suspends use of Merck growth enhancer for cattle b/c some having difficulty walking. Merck says Zilmax safe. Item | Follow @FiercePharma

@CarlyHFierce: ICYMI: On Vivus' Q2 earnings and plans from new CEO Tony Zook (formerly of AstraZeneca) to increase Qsymia sales. More | Follow @CarlyHFierce

> Sanofi faces bribery allegations from China whistleblower. Story

> Wanted: Buyers for Aptalis Pharma. Must be willing to pay $3B-plus. Article

> Endo invests big in Qualitest to push generic growth. More

Vaccines News

> Flu vaccine tablet developer raises $20M. News

> PharmAthene to add antibody assets in Theraclone merger. Item

> Sanofi advances C. diff vaccine into PhIII. More

> Israel buys 500,000 polio vaccines for immunization push. Article

> GSK adding 2-D barcode to 4-in-1 flu vaccine packaging. Story

> Dana-Farber sees promise in leukemia vaccine trial. More

Pharma Manufacturing News

@EricPFierce: Pharma Tech Industries to expand facility in Missouri Story | Follow @EricPFierce

> GAO report says FDA needs clear authority over compounders. News

> Ranbaxy gets site for second Malaysian plant. Story

> When it comes to Viagra, counterfeiters just can get enough. Article

> Endo investing $100M in Qualitest manufacturing. More

> Recall expert takes services to Europe. Item

And Finally… A new study failed to show that probiotics could ward off diarrhea caused by antibiotics in elderly patients. Report